BRAF与TP53突变相互作用定义乳头状甲状腺癌新型预后分层及治疗意义_表4
乳头状甲状腺癌中BRAF/TP53突变互作与预后分层的表4数据,含72例NGS突变分析。

基本信息
资源简介
BRAF与TP53突变相互作用定义乳头状甲状腺癌新型预后分层及治疗意义_表4
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 9.36 KB,主题涵盖 papillary thyroid cancer、BRAF、TERT、TP53、TCGA,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Table 4_Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma.xlsx》。配套论文《Application and recent advances in conventional biomarkers for the prognosis of papillary thyroid carcinoma》发表于 Frontiers in Oncology(2025),DOI:10.3389/fonc.2025.1598934。源站首次发布:2025-09-29。
【数据内容】
源站原始描述:BackgroundPapillary thyroid carcinoma (PTC) requires improved risk stratification through molecular profiling, yet how mutation interactions shape clinical outcomes remains poorly defined. MethodsThis single-center retrospective study analyzed 72 PTC cases using next-generation sequencing to characterize mutation patterns and pathway evolution, with validation against The Cancer Genome Atlas datasets. ResultsWe identified three key molecular features: BRAF mutations (47.2%) predicted recurrence…
【数据结构与技术规格】
文件数 1 个,合计 9.36 KB。Table 4_Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma.xlsx:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,9.36 KB。数据集 DOI:10.3389/fendo.2025.1584618.s004。
【主题与分类】
源站学科分类:Cell Metabolism。主题标签:papillary thyroid cancer、BRAF、TERT、TP53、TCGA、prognosis。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Table_4_Mutation_interactions_of_BRAF_and_TP53_define_novel_prognostic_stratification_and_therapeutic_implications_in_papillary_thyroid_carcinoma_xlsx/30229417
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Liu, Li; Wei, Fang (2025). Table 4_Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma.xlsx. Frontiers. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Table 4_Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma.xlsx
- DOI:10.3389/fendo.2025.1584618.s004
- 发布日期:2025-09-29
- 文件数:1 个
- 文件总体积:9.36 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Table_4_Mutation_interactions_of_BRAF_and_TP53_define_novel_prognostic_stratification_and_therapeutic_implications_in_papillary_thyroid_carcinoma_xlsx/30229417
命令行下载
curl -L -o "Table 4_Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma.xlsx" "https://ndownloader.figshare.com/files/58339906"
文件清单
Table 4_Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma.xlsx(9.36 KB)
文件总体积 9.36 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
BackgroundPapillary thyroid carcinoma (PTC) requires improved risk stratification through molecular profiling, yet how mutation interactions shape clinical outcomes remains poorly defined.
MethodsThis single-center retrospective study analyzed 72 PTC cases using next-generation sequencing to characterize mutation patterns and pathway evolution, with validation against The Cancer Genome Atlas datasets.
ResultsWe identified three key molecular features: BRAF mutations (47.2%) predicted recurrence risk (p By integrating BRAF/TP53 status with conventional staging, we establish a mutation-guided framework that may refine risk prediction and inform treatment strategies, bridging molecular heterogeneity with clinical decision-making. This work provides insights for personalizing thyroid cancer management.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fendo.2025.1584618.s004(source: https://frontiersin.figshare.com/articles/dataset/Table_4_Mutation_interactions_of_BRAF_and_TP53_define_novel_prognostic_stratification_and_therapeutic_implications_in_papillary_thyroid_carcinoma_xlsx/30229417)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




